Related Experiment Video
Updated: Mar 1, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Microparticle Formation in Peritoneal Dialysis: A Proof of Concept Study
Shareef Akbari1, Rima Abou-Arkoub2, Suzy Sun1
1Kidney Research Centre, The Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada.
Microparticles (MPs) form in peritoneal dialysis (PD) fluid, indicating potential mesothelial cell injury. These microparticles may serve as biomarkers for peritoneal membrane damage during PD treatment.
Area of Science:
- Nephrology
- Cell Biology
- Biomarker Discovery
Background:
- Peritoneal dialysis (PD) membrane injury is linked to reduced ultrafiltration capacity.
- No validated biomarkers currently exist for mesothelial cell injury during PD.
- Microparticles (MPs), shed from injured cells, are sensitive indicators of tissue damage.
Purpose of the Study:
- To investigate if peritoneal solution exposure during PD induces mesothelial microparticle (MP) formation.
- To assess if MPs in PD effluent can indicate peritoneal membrane injury.
Main Methods:
- Single-center, proof-of-concept study design.
- Analysis of PD effluent MP levels using electron microscopy, nanoparticle tracking analysis (NTA), flow cytometry, and Western blot.
- Detection of mesothelin, a mesothelial cell marker, on MPs.
Main Results:
- Nanoparticle tracking analysis detected particles in the 30-900 nm range.
- MP levels progressively increased over a 4-hour PD dwell time.
- Electron microscopy and Western blot confirmed MPs contained mesothelin, suggesting mesothelial origin.
Conclusions:
- Microparticles (MPs) are formed and accumulate in the peritoneal cavity during PD.
- MP formation may represent a cellular stress response to PD.
- MP levels in PD effluent show potential as a biomarker for peritoneal membrane damage.
Related Concept Videos
Peritoneal Dialysis I: Introduction and Procedure
Dialysis
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Hemodialysis I: Introduction

